BreStem Therapeutics
Raleigh, US · Founded 2017 · North Carolina corporation
Biotech
Founders & leadership
DZ
Dongmei ZhuNamed on SEC filing
KC
Ke ChengNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3M disclosed across 2 rounds · 2017–2021
▶$3MraisedNov 2021 · 3 investors · Other Health CareRule 506(b)
▶$3MraisedNov 2021 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Weili ZhouDirector
- Weigang WangDirector
- Ke ChengExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Jun 2021
- Incorporated
- Corporation, North Carolina, 2017
- Federal exemptions
- 06b
▶$50KraisedNov 2017 · 1 investors · BiotechnologyRule 506(b)
▶$50KraisedNov 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dongmei ZhuExecutive Officer
- Ke ChengExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $50K
- First sale
- Nov 2017
- Incorporated
- Corporation, North Carolina, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has BreStem Therapeutics raised?
- BreStem Therapeutics has disclosed $3M raised across 2 rounds.
- Where is BreStem Therapeutics headquartered?
- BreStem Therapeutics is headquartered in Raleigh, US.